MedPath

Additional Benefit of Thoracic Impedance Monitoring (TIM) for Propofol-sedation Monitoring During PEG Placement

Not Applicable
Completed
Conditions
Percutaneous Endoscopic Gastrostomy (PEG)
Interventions
Device: thoracic impedance monitoring
Device: pulseoxymetry
Device: non-invasive blood preassure monitoring
Registration Number
NCT04202029
Lead Sponsor
Georg Dultz
Brief Summary

The present study is a randomized, prospective, single-blinded study. A total of 172 patients presenting for percoutaneous endoscopic gastrostomy (PEG) under sedation will be included according to the statistical sample size calculation. Patients will be randomized to either group 1- standard monitoring (pulseoxymetry and non-invasive blood preassure monitoring) or group 2- standard monitoring and thoracic impedance measurement during Propofol-based sedation for PEG. Episodes of Hypoxia are documented and compared in both groups.

Statistical analysis will be done in cooperation with the statistical biomedical institute oft he university hospital in Frankfurt.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
173
Inclusion Criteria
  • > /= 18 years
  • given consent
  • planned PEG
Exclusion Criteria
  • ASA >/= 4
  • no given consent
  • pregnant/laction
  • contraindication against PEG
  • contraindication against propofol-sedatation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
thoracic impedance monitoring armnon-invasive blood preassure monitoringthoracic impedance monitoring arm: standard monitoring and additionally thoracic impedance measurement)
pulseoxymetry armnon-invasive blood preassure monitoringpulseoxymetry arm: standard monitoring: pulseoxymetry and non-invasive blood preassure monitoring
thoracic impedance monitoring armpulseoxymetrythoracic impedance monitoring arm: standard monitoring and additionally thoracic impedance measurement)
thoracic impedance monitoring armthoracic impedance monitoringthoracic impedance monitoring arm: standard monitoring and additionally thoracic impedance measurement)
pulseoxymetry armpulseoxymetrypulseoxymetry arm: standard monitoring: pulseoxymetry and non-invasive blood preassure monitoring
Primary Outcome Measures
NameTimeMethod
comparison of hypoxia in both armsAverage duration period of PEG-placement: approx. 15 minutes.

Hypoxia is defined as oxygen saturation dropping below 90 % for more than 15 seconds. The primary end point is assessed from the beginning of propofol sedation until the PEG-procedure is terminated defined by awaking of the patient.

Secondary Outcome Measures
NameTimeMethod
Comparison of severe hypoxia episodes in both arms defined as oxygen saturation dropping below 85 %Average duration period of PEG-placement: approx. 15 minutes.

Severe hypoxia is defined as O2 saturation below 85%. This end point is assessed from the beginning of propofol sedatio n until the PEG-procedure is terminated defined by awaking of the patient.

Additional cost of thoracic impedance monitoring (TIM)Time frame is the entire study period with a maximum of 3 years.

The costs that are needed to implement TIM during every procedure will be calculated and will be stated in the results. All PEG-placements in the TIM group will be used. By using a 3-lead-ECG, 3 electrodes will be needed per patient. For alle patients, one ECG-cable will be needed. Therefore, the costs will be calculated per patient.

Risk stratification of baseline criteria for hypoxiaTime frame is the entire study period with a maximum of 3 years.

Risk factors will be evaluated in an univariate and a multivariate analyse

Comparison of satisfaction of patients in both armsapprox. 15 minutes

The involved patients will be asked to give there opinion using visual analog scale (VAS). Scale reaches from 1 (dissatisfied) to 10 (satisfied). The end point will be meassured after the procedure. The investigation time is defined as one PEG-placement.

Comparison of severe hypoxia-episodes in both armsAverage duration period of PEG-placement: approx. 15 minutes. This end point is assessed from the beginning of propofol sedation until the PEG-procedure is terminated defined by awaking of the patient.

The number of hypoxia-episodes during each intervention will be assesed. This end point is assessed from the beginning of propofol sedation until the PEG-procedure is terminated defined by awaking of the patient.

Comparison of the time difference of occuring apnoe before hypoxiaAverage duration period of PEG-placement: approx. 15 minutes.

The time difference between the onset of apnoe befpre the onset of hypoxia will be meassured.

Specifity and sensetivity of thoracic impedance monitoringAverage duration period of PEG-placement: approx. 15 minutes.

The specifity and sensitivity will be calculated using the frequency of falls alarms and missed alarms in relation to hypoxia. This end point is assessed from the beginning of propofol sedation until the PEG-procedure is terminated defined by awaking of the patient.

Comparison of intervention procedures to prevent hypoxiaAverage duration period of PEG-placement: approx. 15 minutes.

The necessity to prevent a hypoxic event because of an alarm by the monitoring by elevating the oxygen delivery, using jaw thrust manoeuvre or mask ventilation will be compared in both arms. This end point is assessed from the beginning of propofol sedation until the PEG-procedure is terminated defined by the awaking of the patient.

Comparison of satisfaction of doctors in both armsapprox. 15 minutes

The involved doctors will be asked to give there opinion using visual analog scale (VAS). Scale reaches from 1 (dissatisfied) to 10 (satisfied). The end point will be meassured after the procedure. The investigation time is defined as one PEG-placement.

Comparison of hypoxia-episodes in both armsAverage duration period of PEG-placement: approx. 15 minutes.

Number of hypoxia-episodes during each intervention. This end point is assessed from the beginning of propofol sedation until the PEG-procedure is terminated defined by awaking of the patient.

Comparison of satisfaction of nurses in both armsapprox. 15 minutes

The involved nurses will be asked to give there opinion using visual analog scale (VAS). Scale reaches from 1 (dissatisfied) to 10 (satisfied). The end point will be meassured after the procedure. The investigation time is defined as one PEG-placement.

Trial Locations

Locations (1)

Klinikum der J. W. Goethe-Universität

🇩🇪

Frankfurt am Main, Germany

© Copyright 2025. All Rights Reserved by MedPath